← Back to Clinical Trials
Recruiting NCT06418867

NCT06418867 The Effect of Mindfulness Intervention Program on Adolescents' Internet Addiction

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06418867
Status Recruiting
Phase
Sponsor Kemal Elyeli
Condition Mindfulness
Study Type INTERVENTIONAL
Enrollment 605 participants
Start Date 2024-02-01
Primary Completion 2025-06-01

Eligibility & Interventions

Sex All sexes
Min Age 17 Years
Max Age 19 Years
Study Type INTERVENTIONAL
Interventions
Mindfulness

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 605 participants in total. It began in 2024-02-01 with a primary completion date of 2025-06-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The Internet shows its presence in areas where human beings are actively involved, from education to health, from entertainment to the investment sector. The integration of the Internet into many areas of human life leads to its intensive use. According to the Global Digital Report, the number of individuals with access to the Internet worldwide at the beginning of 2024 is stated as 5.35 billion, and this number constitutes more than 66% of the total world population. One of the pioneering studies on internet addiction was conducted by Young. In this study, five subtypes of internet addiction were identified. These are cyber sex addiction (obsessive use of adult sites such as cyber sex, cyber porn), cyber relationship addiction (excessive involvement in online relationships), net compulsions (online gambling, shopping and trading), information overload (on websites). and constantly surfing databases) and computer addiction (playing computer games). Considering the sub-dimensions of internet addiction, it is seen that it affects many areas of life, from family life to interpersonal relationships, from social life to economic life. Conscious awareness is the awareness of one's internal state and environment. Mindfulness can help people avoid destructive or automatic habits and reactions by learning to observe their thoughts, feelings, and other momentary experiences without judging or reacting. Acting based on awareness is a much different way of life than the autopilot approach in which the individual carries out his daily routines and activities. In studies, mindfulness is examined not only to prevent the recurrence of addiction, but also as a long-term, ongoing health behavior that supports the recovery of addiction. Determining the effect of a mindfulness-based intervention program applied to adolescent nursing students studying at a university on internet addiction and awareness. is intended.

Eligibility Criteria

Inclusion Criteria: * Volunteering to participate in the study * Being in the adolescent age group (17-19 years old) * Studying in Turkish nursing department Exclusion Criteria: • Previous participation in a mindfulness intervention program for internet addiction

Contact & Investigator

Central Contact

Kemal Mr. Elyeli, PhD(c).

✉ kemal.elyeli@neu.edu.tr

📞 5488350090

Frequently Asked Questions

Who can join the NCT06418867 clinical trial?

This trial is open to participants of all sexes, aged 17 Years or older, up to 19 Years, studying Mindfulness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06418867 currently recruiting?

Yes, NCT06418867 is actively recruiting participants. Contact the research team at kemal.elyeli@neu.edu.tr for enrollment information.

Where is the NCT06418867 trial being conducted?

This trial is being conducted at Nicosia, Cyprus.

Who is sponsoring the NCT06418867 clinical trial?

NCT06418867 is sponsored by Kemal Elyeli. The trial plans to enroll 605 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology